Product Description
Pemetrexed Injection is a chemotherapy drug used to treat certain types of cancer, such as lung, mesothelioma, and ovarian cancers. It works by blocking enzymes that cancer cells need to grow and divide. It is usually given by injection into a vein. It is usually given in combination with other chemotherapy drugs. Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infection.
Clinically Proven Oncology SolutionPemetrexed Injection offers an effective, FDA and EMA-approved treatment for malignant pleural mesothelioma and non-small cell lung cancer. Its antineoplastic action targets cancer cells directly, supporting modern oncology protocols. Each vial is part of a quality-assured supply chain, ensuring trusted delivery to healthcare centers and hospitals.
Reconstitution and Administration Made SimpleTo prepare for intravenous use, reconstitute the powder with 20 mL of 0.9% Sodium Chloride Injection. Once dissolved and inspected for particulates or discoloration, the solution should be administered with medical supervision. The product contains no preservatives and is intended for a single use, maximizing patient safety.
Safe Handling and Storage GuidelinesPemetrexed Injection should be stored below 25C and protected from light to maintain efficacy. Healthcare providers should adhere to standard cytotoxic handling procedures. Its 24-month shelf life ensures reliable availability for clinicians and patients. Always follow institutional guidelines for preparation, administration, and disposal.
FAQs of Pemetrexed Injection:
Q: How should Pemetrexed Injection 500 mg/vial be reconstituted?
A: To reconstitute Pemetrexed Injection, add 20 mL of 0.9% Sodium Chloride Injection (without preservatives) to the single-use vial. After gentle swirling, inspect the solution for clarity and absence of particulates or discoloration before intravenous administration.
Q: What indications is Pemetrexed Injection approved for?
A: Pemetrexed Injection is approved for the treatment of malignant pleural mesothelioma and non-small cell lung cancer, as directed by a qualified healthcare professional.
Q: When should Pemetrexed Injection not be used?
A: This injection is contraindicated in patients with a known hypersensitivity to pemetrexed disodium or any of its excipients. It should not be used in such cases to avoid serious allergic reactions.
Q: Where should the prepared solution be administered?
A: The reconstituted Pemetrexed solution must be administered by intravenous infusion in a clinical setting, under the supervision of trained medical personnel following established protocols.
Q: What are the benefits of using Pemetrexed Injection in cancer therapy?
A: As an alkylating agent with antineoplastic activity, Pemetrexed selectively targets cancer cells, helping to slow disease progression and improve clinical outcomes for eligible patients with mesothelioma or non-small cell lung cancer.
Q: How long can Pemetrexed Injection be stored, and under what conditions?
A: Unopened vials should be stored below 25C and protected from light. The product maintains a shelf life of 24 months under these recommended conditions.